Management of airway mucus hypersecretion in chronic airway inflammatory disease: Chinese expert consensus (English edition)

Yongchun Shen; Shaoguang Huang; Jian Kang; Jiangtao Lin; Kefang Lai; Yongchang Sun; Wei Xiao; Lan Yang; Wanzhen Yao; Shaoxi Cai; Kewu Huang; Fuqiang Wen

doi:10.2147/COPD.S144312

Management of airway mucus hypersecretion in chronic airway inflammatory disease: Chinese expert consensus (English edition)

Int J Chron Obstruct Pulmon Dis. 2018 Jan 30:13:399-407. doi: 10.2147/COPD.S144312. eCollection 2018.

Authors

Yongchun Shen¹, Shaoguang Huang², Jian Kang³, Jiangtao Lin⁴, Kefang Lai⁵, Yongchang Sun⁶, Wei Xiao⁷, Lan Yang⁸, Wanzhen Yao⁶, Shaoxi Cai⁹, Kewu Huang¹⁰, Fuqiang Wen¹

Affiliations

¹ Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University and Division of Pulmonary Diseases, State Key Laboratory of Biotherapy of China, Chengdu.
² Department of Pulmonary Disease, Ruijin Hospital, Shanghai Jiao Tong University, Shanghai.
³ Department of Respiratory Medicine, Institute of Respiratory Diseases, The First Affiliated Hospital of China Medical University, Shenyang.
⁴ Department of Respiratory Diseases, China-Japan Friendship Hospital, Beijing.
⁵ State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Diseases, First Affiliated Hospital of Guangzhou Medical University, Guangzhou.
⁶ Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing.
⁷ Department of Respiratory Medicine, Qilu Hospital of Shandong University, Jinan.
⁸ Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an.
⁹ Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou.
¹⁰ Division of Pulmonary and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People's Republic of China.

Abstract

Airway mucus hypersecretion is one of the most important characteristics of chronic airway inflammatory diseases. Evaluating and managing airway mucus hypersecretion is of great importance for patients with chronic airway inflammatory diseases. This consensus statement describes the pathogenesis, clinical features, and the management of airway mucus hypersecretion in patients with chronic airway inflammatory diseases in the People's Republic of China. The statement has been written particularly for respiratory researchers, pulmonary physicians, and patients.

Keywords: COPD; asthma; bronchiectasis; cystic fibrosis; mucus; treatment.

Publication types

Practice Guideline
Review

MeSH terms

Animals
Asthma / diagnosis
Asthma / physiopathology
Asthma / therapy*
Bronchiectasis / diagnosis
Bronchiectasis / physiopathology
Bronchiectasis / therapy*
China
Consensus
Cystic Fibrosis / diagnosis
Cystic Fibrosis / physiopathology
Cystic Fibrosis / therapy*
Drainage / adverse effects
Drainage / standards*
Expectorants / adverse effects
Expectorants / therapeutic use*
Humans
Lung / metabolism*
Lung / physiopathology
Mucus / metabolism*
Pulmonary Disease, Chronic Obstructive / diagnosis
Pulmonary Disease, Chronic Obstructive / physiopathology
Pulmonary Disease, Chronic Obstructive / therapy*
Pulmonary Medicine / standards*
Treatment Outcome

Substances

Expectorants